Showing results (1-10 of 257) with videos related to
Sort By:
Pageof 26
Current Cancer Drug Targets|November 10, 2015
Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?Giandomenico Roviello, Daniele GeneraliMedical Oncology (Northwood, London, England)|February 2, 2018
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysisGiandomenico Roviello, Daniele GeneraliEuropean Journal of Cancer (Oxford, England : 1990)|July 28, 2026
Methodological considerations in the interpretation of ASCENT-03Francesca Poggio, Daniele GeneraliDrug Design, Development and Therapy|March 3, 2018
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancerSilvia Paola Corona, Daniele GeneraliHeliyon|January 1, 2024
Therapeutic resistance and optimal drug sequencing in HER2-positive metastatic breast cancer: unmet needs and future perspectivesFrancesco Schettini, Fabiola Giudici, Daniele GeneraliMedical Oncology (Northwood, London, England)|August 31, 2017
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysisGiandomenico Roviello, Silvia Paola Corona, Daniele GeneraliBreast (Edinburgh, Scotland)|January 8, 2014
Neoadjuvant treatment of HER2 and hormone-receptor positive breast cancer - moving beyond pathological complete responseSerena Di Cosimo, Grazia Arpino, Daniele GeneraliCancer Treatment Reviews|November 29, 2011
Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impactChiara Foroni, Massimo Broggini, Daniele Generali, et al.Investigational New Drugs|March 13, 2017
Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysisGiandomenico Roviello, Chiara Pacifico, Paola Corona, et al.International Journal of Environmental Research and Public Health|March 10, 2022
Patients' Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020Lorenzo Palamenghi, Fabiola Giudici, Guendalina Graffigna, et al.Pageof 26